About Vizir Analytical

Pharmaceutical quality intelligence, built for accountable decisions.

Vizir Analytical LLC develops VIQMS, a controlled decision-support platform for pharmaceutical quality operations. VIQMS helps teams organize complex source material, assess quality-system events, and prepare reviewable outputs—without transferring accountability away from qualified personnel.

Our purpose

Make complex quality work more structured, traceable, and reviewable.

Quality organizations must act on large volumes of laboratory records, deviations, investigations, procedures, batch documentation, and regulatory correspondence. The challenge is not simply speed. It is preserving context, showing the evidence behind a conclusion, and knowing when uncertainty requires escalation.

Vizir Analytical builds systems that support this work through controlled workflows, structured information capture, evidence-linked analysis, and human review gates. AI-assisted functions are used where they add value, but they remain governed by defined controls and qualified oversight.

What we build

A focused platform for pharmaceutical quality-system work.

VIQMS

Quality event intelligence

VIQMS supports the intake, structuring, routing, and assessment of GMP/QMS events. It is designed for use cases such as OOS and OOT events, invalid tests, deviations, data-integrity concerns, and investigation workflows.

The objective is consistent handling of relevant facts, clear escalation pathways, and documentation that remains reviewable by QA and subject-matter experts.

Decision support only. Vizir Analytical tools do not make batch-release decisions, approve investigations, or issue regulatory determinations. Authorized quality personnel retain responsibility for conclusions, approvals, and actions.
How we work

Built for systems that must withstand review.

01 · Source-grounded

Evidence stays connected

Outputs are designed to remain linked to the records, statements, and contextual information that support them. The goal is not a persuasive answer; it is an inspectable one.

02 · Risk-proportionate

Controls scale with impact

Potential impact to product quality, patient safety, data integrity, and regulatory compliance informs how a function is reviewed, validated, monitored, and escalated.

03 · Human-governed

Qualified review remains essential

Confidence gates and review controls are built into the workflow so that uncertainty, high-risk cases, and material decisions are routed to qualified personnel.

04 · Traceable

Versioned and reproducible

Controlled versions of datasets, prompts, evaluation artifacts, and outputs support reproducibility, change control, and a clear audit trail.

05 · Transparent

Limitations are surfaced

Boundary cases, missing evidence, contradictions, and uncertainty are treated as material findings for review—not hidden behind automated confidence.

06 · Lifecycle-oriented

Not a one-time deployment

Evaluation, monitoring, controlled change, and periodic reassessment are treated as continuing responsibilities across the life of a quality-support system.

Our operating model

Technology in service of pharmaceutical quality practice.

Vizir Analytical combines pharmaceutical quality-system experience with applied machine-learning and information-structure methods. We focus on practical implementation: the source records teams already use, the review steps they already perform, and the governance needed for the resulting outputs to be useful in a regulated environment.

Our role is to help quality teams work with more structure and consistency—not to replace scientific judgment, procedural ownership, or the responsibility of authorized QA personnel.

Discuss your quality-system use case.

For demonstrations, collaborations, or discussions about controlled pharmaceutical quality intelligence with VIQMS.

Contact us